Similar articles

• Lack of specificity of HTLV antibody enzyme immunoassays.

  Jang D, Mahony JB, Sellors JW, Galli R, Gregory B, Chernesky MA. Jang D, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 15;9(5):523-4. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7627628 No abstract available.
• [Retrovirus: diagnostic tests and their interpretation (II). HIV-2, HTLV-I, and HTLV-II infection].

  Soriano V, Gutiérrez M, González-Lahoz J. Soriano V, et al. Med Clin (Barc). 1993 Sep 11;101(7):264-8. Med Clin (Barc). 1993. PMID: 7746003 Review. Spanish. No abstract available.
• HTLV-I/II seroprevalence in 55 Brazilian patients with idiopathic uveitis.

  Pinheiro SR, Carneiro-Proietti AB, Lima-Martins MV, Proietti FA, Pereira AA, Oréfice F. Pinheiro SR, et al. Rev Soc Bras Med Trop. 1996 Jul-Aug;29(4):383-4. doi: 10.1590/s0037-86821996000400014. Rev Soc Bras Med Trop. 1996. PMID: 8768591 No abstract available.
• Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil.

  Jacob F, Santos-Fortuna E, Azevedo RS, Caterino-de-Araujo A. Jacob F, et al. J Clin Virol. 2008 Jun;42(2):149-55. doi: 10.1016/j.jcv.2008.01.017. Epub 2008 Mar 17. J Clin Virol. 2008. PMID: 18346935
• [Human T-lymphotrophic virus type I and II--diagnosis and clinical presentation].

  Christiansen CB. Christiansen CB. Ugeskr Laeger. 1994 Dec 19;156(51):7663-7. Ugeskr Laeger. 1994. PMID: 7839528 Review. Danish.